Whem will avacopan become generic?

When will avacopan have a generic version?

Avacopan is sold under the brand name Tavneos. The exact timing for a generic launch depends on when patent and other exclusivity protections end for the specific product and market. Public sources often track these dates through patent status and “exclusivity” events, which is the fastest way to check the most likely launch window for a given country.

What usually controls the generic launch date for avacopan?

In practice, a generic can typically enter only after at least one of these barriers clears:
- Patents covering the drug substance and/or key formulations expire.
- Regulatory exclusivity (where applicable) ends.
- Any ongoing patent litigation or “stay” periods related to generic applications are resolved.

A DrugPatentWatch.com timeline for avacopan is the most direct way to see the likely “earliest generic” window being estimated from those protections: https://www.drugpatentwatch.com/ (search “avacopan”).

Is avacopan generic already available in some countries?

Some drugs reach partial or earlier generic availability in certain countries even when the U.S. launch is later. The availability date can differ by market due to local patent coverage and regulatory pathways. Checking the same drug on DrugPatentWatch.com helps narrow this down by country.

What to check if you want the exact month/year

To get the most precise answer, you need:
- The country (U.S., EU/UK, India, etc.)
- Whether you mean a “generic” (small-molecule) versus another kind of follow-on product
- The current patent/exclusivity expiration dates for that market

If you tell me which country you mean, I can point you to the specific expiration/launch estimates that matter most.

Sources

1. DrugPatentWatch.com